Sun Care Products Market Overview, Analysis And Forecast To 2028: Grand View Research Inc.

 Sun Care Products Market Growth & Trends

The global sun care products market is expected to reach USD 14.7 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 4.0% from 2021 to 2028. Sun care products are gaining popularity among consumers owing to the rising awareness of the effects of UV rays on the human skin. Moreover, consumers’ concerns about the signs of skin aging due to increased sun exposure are expected to drive the market.

The adult sun cream held the largest revenue share in 2020 and is expected to maintain its dominance over the forecast period. Sun cream for adults is used to prevent the skin from sunburn and early signs of aging such as wrinkles and leathery skin. The ability to protect against a high risk of skin cancer, skin discoloration, and inflammation is expected to improve sales in the coming years.

The hypermarket and supermarket segment held the largest revenue share in 2020 and is expected to maintain dominance over the forecast period. A large number of consumers prefer buying sunscreen products from hypermarkets and supermarkets due to the shopping experience offered by these stores. The ability to physically verify these products, along with expert assistance, is another major factor contributing to this distribution channel’s growth.

Europe made the largest contribution to the global market in 2020. Rising awareness among consumers regarding the harmful effects of prolonged sun exposure on the skin has helped boost product demand across the region. Furthermore, an increasing number of products that offer various additional benefits such as dark spot reduction, anti-aging have further fueled product demand.

The market is fragmented in nature, with the presence of a large number of global and regional players. Beiersdorf AG, Groupe Clarins, Johnson & Johnson, Coty Inc., Shiseido Co. Ltd., L'oreal, The Estee Lauder Companies Inc., Burt's Bees, Bioderma Laboratories, Unilever are among the prominent players in the global market.

Request a free sample copy or view report summary: Sun Care Products Market Report

Sun Care Products Market Report Highlights

• The adult sun cream segment dominated the market and accounted for a 69.4% share of the overall revenue in 2020. Increasing trend of tan lines without actually going out in the sunlight is expected to drive the market
• In terms of distribution channel, the hypermarket and supermarket segment accounted for a 48.5% share of the overall revenue in 2020
• Europe held the largest revenue share of 35.1% in 2020, due to growing awareness among consumers in the region regarding the benefits of using sunscreen products
• Product innovation and new launches emerged as the key strategy deployed by majority of market players to stay abreast of the competition

Access Press Release@ https://www.grandviewresearch.com/press-release/global-sun-care-products-market

Sun Care Products Market Segmentation

Grand View Research has segmented the global sun care products market on the basis of product, distribution channel, and region:

Sun Care Products Outlook (Revenue, USD Million, 2016 - 2028)

• Adult Sun Cream
• Baby Sun Cream
• After Sun
• Fake Tan/Self Tan
• Tanning

Sun Care Products Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

• Hypermarket & supermarket
• Pharmacy & drug store
• Specialty store
• Online
• Others

Sun Care Products Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
• Europe
  • Germany
  • UK.
  • France
• Asia Pacific
  • China
  • Japan
• Central & South America
  • Brazil
• Middle East & Africa
  • South Africa

List of Key Players of Sun Care Products Market

• Beiersdorf AG
• Groupe Clarins
• Johnson & Johnson
• Coty Inc.
• Shiseido Co. Ltd.
• L'oreal
• The Estee Lauder Companies Inc.
• Burt's Bees
• Bioderma Laboratories
• Unilever

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Network Point-of-Care Glucose Testing Market to Exhibit Impressive Growth During 2021 – 2028: Grand View Research Inc.

 Network Point-of-Care Glucose Testing Market Growth & Trends

The global network point-of-care glucose testing market size is expected to reach USD 1.6 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 3.9% from 2021 to 2028. Increasing demand for safe and accurate remote patient monitoring options and the need for data-based treatment regimens are major factors driving the market. The integration of advanced technologies including Bluetooth Low Energy (BLE) and Infrared is expected to fuel the market growth in the upcoming years.

Expanding patient base in Asia Pacific and the Middle East and the high demand for advanced diabetes management systems are creating significant growth opportunities in these regions. These regions also include some of the highly preferred destinations for medical tourism. Increasing demand for world-class healthcare services and rising adoption of advanced technology are some of the factors boosting the market growth in these regions.

Network point-of-care glucose meters were extensively used in COVID-19 care. This enabled doctors to remotely observe glucose levels with minimal risk of infection. In addition, a large amount of data is still being used to customize treatment plans for diabetic COVID-19 patients. Preference for telemedicine and trends of home healthcare settings for chronic patients are some of the factors expected to expand the applications of network-based point-of-care devices.

Request a free sample copy or view report summary: Network Point-of-Care Glucose Testing Market Report

Network Point-of-Care Glucose Testing Market Report Highlights

• Network point-of-care devices were in high demand during the first and second wave of COVID-19 owing to their advantage of remote patient monitoring
• Based on product, the Accu-Chek Inform II segment held the largest revenue share in 2020 and is expected to expand at a lucrative growth rate during the forecast period
• North America held the largest revenue share in 2020 and is predicted to maintain its lead over the forecast period owing to the factors such as the presence of major players and high adoption rate

Access Press Release@ https://www.grandviewresearch.com/press-release/global-network-point-of-care-glucose-testing-market

Network Point-of-Care Glucose Testing Market Segmentation

Grand View Research has segmented the global network point-of-care glucose testing market on the basis of product and region:

Network Point-of-Care Glucose Testing Product Outlook (Revenue, USD Million, 2016 - 2028)

• i-STAT
• Accu-Chek Inform II
• StatStrip
• HemoCue
• CareSens Expert Plus
• BAROzen H Expert Plus

Network Point-of-Care Glucose Testing Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Network Point-of-Care Glucose Testing Market

• Hoffmann-La Roche Ltd.
• Abbott
• Nova Biomedical
• Bayer AG/Ascensia Diabetes Care Holdings AG
• Danaher

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. Restricted Access Barrier System Market is Projected to Boost USD 249.4 Million by 2028: Grand View Research Inc.

 U.S. Restricted Access Barrier System Market Growth & Trends

The U.S. restricted access barrier system market size is expected to reach USD 249.4 million by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 4.7% from 2020 to 2028. The market is primarily driven by the growth of the biotechnology industry in the U.S. due to technological advancements, an increasing number of small-scale biopharma companies, and rising investments in research.

Technological breakthroughs in biopharmaceutical and biotechnology manufacturing are expected to surge the market growth over the forecast period. The demand for modular equipment having the ability to reduce the time required for drug production and minimize the overall production cost is anticipated to provide a major boost to the market growth in the U.S.

The COVID-19 pandemic has reinstated the significance of collaborations; many life science companies are partnering among themselves to enhance R&D in the field of biotechnology. The pandemic has accelerated the need for sustainable development, energy conservation, and green pharmaceutical manufacturing, thereby influencing product development in the restricted access barrier systems (RABS) market.

A growing trend of contract development and manufacturing organization (CDMO) for aseptic manufacturing is expected to augment the demand for RABS. Contract manufacturers such as Aenova Group, DPT Laboratories, and Recipharm AB are focusing on new contracts in the U.S., in turn, positively impacting the market growth.

Request a free sample copy or view report summary: U.S. Restricted Access Barrier System Market Report

U.S. Restricted Access Barrier System Market Report Highlights

• The pharmaceutical application segment accounted for the largest share of 64.5% in 2020 owing to the growing pharmaceutical industry in the U.S., coupled with advantages such as a faster changeover process and easy handling
• The medical application segment is expected to expand at a CAGR of 3.9% from 2020 to 2028. This is attributed to the growing penetration of RABS in this segment owing to its ability to provide septic safety in the critical zone and flexibility for interventions
• The U.S. government is aiming to reduce the reliance on drugs manufactured outside the U.S. by encouraging pharmaceutical companies to set up manufacturing facilities in the U.S., in turn, augmenting the demand for RABS
• In February 2021, Comecer spA partnered with Illuminate Manufacturing Intelligence, a division of ATS (ATA.TO), to develop a production solution integrating its containment equipment portfolio in line with Industry 4.0

Access Press Release@ https://www.grandviewresearch.com/press-release/us-restricted-access-barrier-system-market-analysis

U.S. Restricted Access Barrier System Market Segmentation

Grand View Research has segmented the U.S. restricted access barrier system market on the basis of application:

U.S. Restricted Access Barrier System Application Outlook (Revenue, USD Million, 2017 - 2028)

• Pharmaceutical
• Chemical Manufacturing
• Medical
• Others

List of Key Players of the U.S. Restricted Access Barrier System Market

• M.A. Industria Macchine Automatiche S.P.A.
• Germfree Laboratories, Inc.
• Extract Technology
• AZBIL TELSTAR, S.L.U.
• Syntegon Technologies GmbH
• Isolation Systems Inc.
• Shanghai Tofflon Science and Technology Co., Ltd.
• Ortner Reinraumtechnik GmbH
• COMECER S.p.A.
• SKAN AG

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Anti-Vascular Endothelial Growth Factor Therapeutics Market Will Be Worth USD 12.82 Billion by 2028: Grand View Research Inc.

 Anti-Vascular Endothelial Growth Factor Therapeutics Market Growth & Trends

The global anti-vascular endothelial growth factor therapeutics market size is expected to reach USD 12.82 billion by 2028, registering a CAGR of 0.5% over the forecast period, according to a new report by Grand View Research, Inc. Increased funding for R&D of anti-VEGF therapeutics to boost the development of new drugs is expected to accelerate market growth. Moreover, the introduction of novel innovative products coupled with the increasing geriatric population that is susceptible to develop ophthalmic diseases is expected to propel the market growth over the forecast period.

According to the United Nations Department of Economic and Social Affairs data, the global elderly population (aged 60 years and above) was around 703 million in 2019. The share of the population aged 65 years and above was 6%, which increased to 9% in 2019. The aging population, based on countries, was around 68.7 million in Africa, 549.2 million in Asia, 183 million in Europe, 78.4 million in North America, and more than 76 million in Latin America & other regions in 2017. Hence, the increasing geriatric population is anticipated to drive the market.

The lack of reimbursement policies in developing regions is creating an opportunity for cost-effective novel molecules. In addition, ophthalmologists switching to more effective newly launched drugs has compelled companies to invest in R&D to maintain their industry position. The interest of investigators on biosimilar of existing drugs is a major trend in the pipeline of anti-VEGF therapeutics.

Moreover, companies are developing various formulations and drug delivery systems that may increase the adoption of these therapies. For instance, F. Hoffmann La Roche Ltd. is developing the port delivery system-RG6321 (Ranibizumab)-which is currently undergoing a phase III clinical trial. It is an eye implant that is refillable and continuously delivers a customized formulation of ranibizumab over a period of months.

Loss of patent protection is likely to have a negative impact on the market growth and has led big pharma companies to consider new revenue streams. However, this is creating an emerging market for biosimilar drug producers in the space. This rising competition is anticipated to impede market growth. However, the launch of novel products with a competitive advantage is anticipated to lower the impact of the restraint during the forecast period.

Request a free sample copy or view report summary: Anti-Vascular Endothelial Growth Factor Therapeutics Market Report

Anti-Vascular Endothelial Growth Factor Therapeutics Market Report Highlights

• In 2020, Age-related Macular Degeneration (AMD) accounted for the largest revenue share and is anticipated to maintain its dominance over the forecast period
• Diabetic retinopathy is anticipated to witness significant growth over the forecast period due to increasing cases of diabetes across the globe
• The Beovu segment is expected to grow at the fastest CAGR over the forecast period due to the geographic expansion and patent exclusivity
• Product expansions in various geographic regions are expected to increase sales and customer base
• North America was the largest regional market in 2020 due to the high disease prevalence, rising consumer awareness, proactive government measures, technological advancements, and improvements in healthcare infrastructure
• Asia Pacific is anticipated to witness the fastest CAGR over the forecast period due to a rise in the penetration of anti-VEGF products, rising disposable income, and growing consumer awareness

Access Press Release@ https://www.grandviewresearch.com/press-release/global-anti-vascular-endothelial-growth-factor-therapeutics-market

Anti-Vascular Endothelial Growth Factor Therapeutics Market Segmentation

Grand View Research has segmented the global Anti-Vascular Endothelial Growth Factor Therapeutics Market on the basis of products, disease, and region:

Anti-VEGF Therapeutics Product Outlook (Revenue, USD Million, 2017 - 2028)

• Eylea
• Lucentis
• Beovu

Anti-VEGF Therapeutics Disease Outlook (Revenue, USD Million, 2017 - 2028)

• Macular Edema
• Diabetic Retinopathy
• Retinal Vein Occlusion
• Age-related Macular Degeneration

Anti-VEGF Therapeutics Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US
  • Canada
• Europe
  • UK.
  • Germany
  • Spain
  • France
  • Italy
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa

List of Key Players of Anti-Vascular Endothelial Growth Factor (VEGF) Therapeutics Market

• Hoffmann-La Roche Ltd.
• Biogen
• Pfizer, Inc.
• CoherusBioSciences
• Amgen, Inc.
• Bausch Health Companies, Inc.
• Viatris, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Extracorporeal CO2 Removal Devices Market Trends, Demand, Production, Analysis and Forecast to 2028: Grand View Research Inc.

 Extracorporeal CO2 Removal Devices Market Growth & Trends

The global extracorporeal CO2 removal devices market size is estimated to reach USD 118.64 million by 2028, registering a CAGR of 5.27% over the forecast period, according to a new report by Grand View Research, Inc. Technological improvements have changed extracorporeal techniques for CO2 removal in a promising manner to avoid respiratory failure, worsening respiratory acidosis, and to possibly shorten or prevent the duration of invasive mechanical ventilation in patients with exacerbation of asthma and Chronic Obstructive Pulmonary Disease (COPD).

Extracorporeal CO2 removal devices are considered to be an efficient therapy for patients suffering from hypercapnia respiratory failure and may allow clinicians as well as healthcare professionals to improve lung-protective ventilation. These devices can remove adequate CO2 to allow a 50% reduction in alveolar minute ventilation resulting in a substantial reduction in PaCO2. Hence, various advantages associated with these devices are expected to augment the overall market growth.

Extracorporeal CO2 removal devices are effective, safe, and feasible. The usage of these tools in ventilation support has been suggested in clinical situations where they may be useful, including exacerbation of COPD and Acute Respiratory Distress Syndrome (ARDS). The increasing prevalence of COPD across the globe is predicted to accelerate market growth. According to the British Lung Association, around 1.2 million people are diagnosed with COPD in the U.K.

Several manufacturers in the market are focusing on developing technologically advanced and innovative devices to strengthen their industry position. For instance, in November 2015, Alung Technologies received an Expedited Access Pathway (EAP) from the FDA for its Hemolung Respiratory Assist System (RAS). In February 2016, Alung Technologies received USD 12 million financing from existing as well as new investors. This financing helped in the commercialization of Hemolung RAS.

Request a free sample copy or view report summary: Extracorporeal CO2 Removal Devices Market Report

Extracorporeal CO2 Removal Devices Market Report Highlights

• Extracorporeal CO2 machines held the largest revenue share of the global market in 2020 owing to the availability of a wide range of devices
• The COPD application segment accounted for a significant revenue share of the global market in 2020
• The venovenous access segment is expected to account for the largest share by 2028 due to advantages, such as decreased invasiveness, and potential for the early mobilization of patients
• The hospitals end-use segment is estimated to have the fastest CAGR over the forecast period due to the rising number of hospitals in developing economies and increasing competition in healthcare service providers
• North America held the largest market share in 2020 and is anticipated to maintain its dominance over the forecast period
• This is attributable to the growing prevalence of COPD & ARDS and the increasing adoption of advanced devices

Access Press Release@ https://www.grandviewresearch.com/press-release/global-extracorporeal-co2-removal-devices-market

Extracorporeal CO2 Removal Devices Market Segmentation

Grand View Research has segmented the global extracorporeal CO2 removal devices market on the basis of product, application, access, end use, and region:

Extracorporeal CO2 Removal Devices Product Outlook (Revenue, USD Million, 2016 - 2028)

• Extracorporeal CO2 Machines
• Disposables
• Others

Extracorporeal CO2 Removal Devices Application Outlook (Revenue, USD Million, 2016 - 2028)

• ARDS
• COPD
• Bridge to Lung Transplant
• Others

Extracorporeal CO2 Removal Devices Access Outlook (Revenue, USD Million, 2016 - 2028)

• Venovenous
• Arteriovenous

Extracorporeal CO2 Removal Devices End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Clinics
• Others

Extracorporeal CO2 Removal Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Extracorporeal CO2 Removal Devices Market

• Medtronic
• Getinge AB
• Xenios AG
• Alung Technologies
• ESTOR SpA
• Medica SpA
• Aferectica Srl

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Medical Supply Delivery Service Market Is Expected To Accomplish A Valuation Of Around USD 101.3 Billion By 2028: Grand View Research Inc.

 Medical Supply Delivery Service Market Growth & Trends

The global medical supply delivery service market size is expected to reach USD 101.3 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 9.3% from 2021 to 2028. The growing need for ensuring quick, safe, and secure transportation of samples and specimens for testing, reducing logistics costs, and increasing focus on improving the healthcare system is increasing the demand for medical supply delivery services. The increasing incidence of road accidents owing to various factors leading to blood loss and immediate requirement for blood is boosting the market growth. Furthermore, the growing geriatric population, rising incidence of diabetes and hypertension, and the rising surgical procedures for organ transplants are driving the market growth.

The medical supplies application segment accounted for the largest revenue share in 2020 owing to the increasing incidence of chronic diseases, rise in the number of surgical procedures, growing geriatric population, and the increase in the prevalence of chronic diseases across the globe. The lab specimens and reports segment is expected to exhibit the fastest growth rate during the forecast period owing to the growing prevalence of COVID-19 and increasing demand for testing services to combat the disease spread. In addition, the segment is expected to witness an increase in the adoption of these services for the timely supply of time-sensitive samples to avoid contamination.

In 2020, the courier delivery mode of service segment held the largest revenue share due to the rise in demand for medical couriers for transporting confidential and time-sensitive health care items to the end-users. It will include prescription medications, paperwork, medical specimens, lab work, infusion medicine, equipment, and supplies. The drone delivery segment is anticipated to register the fastest growth rate during the forecast period. It is due to the increase in the adoption of drones for timely and contactless transportation of emergency supplies to urban and rural areas, where transportation is expected to be challenging.

The pharmacies end-user segment accounted for the largest revenue share in 2020 owing to the rising prevalence of chronic diseases, technological advancements, increasing demand for drugs and vaccines, and rising adoption of these services to support last-mile delivery of prescription-based and other medications. The patients segment is anticipated to be the fastest-growing segment during the forecast period owing to the increasing prevalence of chronic conditions and growing demand for at-home delivery to avoid in-person visits to pharmacies.

In 2020, Asia Pacific dominated the market. It can be attributed to the rise in the adoption of new technologies, the growing geriatric population, and the increasing demand for blood and blood components required for various procedures. Europe is expected to be the fastest-growing regional market during the forecast period owing to infrastructure investments, higher labor costs amidst workforce shortages, evolving care models, and advancements in warehousing facilities.

Request a free sample copy or view report summary: Medical Supply Delivery Service Market Report

Medical Supply Delivery Service Market Report Highlights

• The medical supplies application segment dominated the market in 2020 due to the increasing incidence of chronic diseases and the growing geriatric population undergoing various minor or major surgical procedures
• By mode of service, the courier delivery segment dominated the market in 2020 owing to the increasing adoption of these services for on-time transportation of time-sensitive healthcare items to reduce turnaround time and avoid contamination
• The pharmacies end-user segment dominated the market in 2020 owing to the rising geriatric population and increasing demand for drugs and vaccines amid the COVID-19 pandemic
• Asia Pacific dominated the market in 2020 owing to a large population and increasing technological advancements in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-medical-supply-delivery-service-market

Medical Supply Delivery Service Market Segmentation

Grand View Research, has segmented the global medical supply delivery service market based on application, mode of service, end-user, and region:

Medical Supply Delivery Service Application Outlook (Revenue, USD Million, 2016 - 2028)

• Medical Supplies
• Drug Supplies
• Emergency Services
• Lab Specimens & Reports

Medical Supply Delivery Service Mode Of Service Outlook (Revenue, USD Million, 2016 - 2028)

• Courier Delivery
• Drone Delivery

Medical Supply Delivery Service End-user Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Clinics
• Laboratories
• Pharmacies
• Patients
• Others

Medical Supply Delivery Service Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • Spain
  • France
  • Italy
  • Russia
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Medical Supply Delivery Service Market

• DHL International GmbH
• United Parcel Service of America, Inc.
• Agility
• ModivCare Solutions, LLC
• FedEx
• CEVA Logistics
• wingslogistics
• International SOS
• Matternet
• Zipline
• Flirtey
• Swoop Aero

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Stoma Care Market Outlook, Leading Manufacturers, Industry Analysis And Forecast: Grand View Research Inc.

 Stoma Care Market Growth & Trends

The global stoma care market size is expected to reach USD 785.6 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.6% from 2021 to 2028. Increasing cases of colorectal cancer, inflammatory bowel disease (IBD), increasing adoption of advanced technologies, and rising awareness regarding stoma care products are the key driving factors for the market.

Colorectal cancer is the most common cause of stomas, accounting for about 45.6% of all cases. More than 45.0% of colostomies are performed in ostomy patients aged 60 above, thereby surging the demand for healthcare products. In addition, colorectal cancer is the third most common form of cancer in both men and women. For instance, according to the report published by the World Health Organization (WHO), in 2020,9,35,000 deaths were reported out of 1.93 million cases due to colorectal cancer. Although it is more prevalent in adults aged 50 and older, however, the incidence rate has increased by 2.2% annually in individuals younger than 50 years.

For instance, according to the American Cancer Society, about 1.4 lakh individuals were diagnosed with colorectal cancer in 2020 of which 12.00% were individuals younger than 50. Furthermore, according to the National Center for Biotechnology Information (NCBI), colorectal cancer is the deadliest among males in UAE and deadliest among females in Japan. Therefore, such instances indicate a considerable increase in demand for healthcare products, as it is one of the essential requirements for treating such cases, thereby propelling market growth over the forecast period.

Request a free sample copy or view report summary: Stoma Care Market Report

Stoma Care Market Report Highlights

• In terms of revenue, the others segment held the largest revenue share in 2020. The rising number of ostomies across the globe is the major factor propelling the segment growth
• The colostomy segment held the largest revenue share in 2020 and is expected to witness a considerable growth rate over the forecast period due to the increasing prevalence of colon cancer
• The home care settings segment held the largest revenue share in 2020. The segment growth is majorly driven by the outbreak of COVID-19 across the globe and the patients opting for homecare services
• In Asia Pacific, the market is anticipated to witness the fastest growth rate over the forecast period due to the adoption of advanced technologies required for stoma care, high population base, and rising awareness about ostomy care

Access Press Release@ https://www.grandviewresearch.com/press-release/global-stoma-care-market

Stoma Care Market Segmentation

Grand View Research has segmented the global stoma care market on the basis of product, application, end-use, and region:

Stoma Care Product Outlook (Revenue, USD Million, 2016 - 2028)

• Closed Bags
• Open/ drainable Bags
• One-piece Bags
• Two-piece Bags
• Others

Stoma Care Application Outlook (Revenue, USD Million, 2016 - 2028)

• Colostomy
• Ileostomy
• Urostomy

Stoma Care End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Home Care Settings
• Hospitals
• Others

Stoma Care Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa
  • Saudi Arabia

List of Key Players of Stoma Care Market

• Coloplast
• Braun Melsungen AG
• Hollister Incorporated
• ConvaTec Inc.
• Salts Healthcare
• Welland Medical Limited

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Pneumatic Nebulizers Market Top Players, Segments, Cost Structure, Demand, Sales | 2028 Forecast

Pneumatic Nebulizers Market Growth & Trends

The global pneumatic nebulizers market size is anticipated to reach USD 1.02 billion by 2028, registering a CAGR of 6.0% over the forecast period, according to a new report by Grand View Research, Inc. The market has shown constant growth in the adoption of pneumatic nebulizers as home healthcare devices have been gaining popularity in recent years. Miniaturization of products and technological advancements are also boosting the adoption of home healthcare devices.

As per the Minnesota Department of Health, administration of medication through nebulizer represents a lower infection risk as compared to other aerosol-producing procedures. On the other hand, according to ISAM, aerosols from the nebulizer do not carry viral particles derived from the patient as they are generated from the fluid in the nebulized chamber, which is a non-patient source. Aerosols generated by nebulizers comprise pathogens only when the healthcare workers or patients contaminate the nebulizers. Various recommendations from institutes do not clarify whether it is appropriate to use nebulizers during the pandemic.

However, there are no known cases of passive infection due to nebulizers. Also, the risk of infection, if any, can be avoided if proper COVID-19 precautions are taken. Therefore, the pandemic affected the overall market only to a certain extent. Revolutionary technological progress is rapidly transforming the market. These expansions are producing lucrative potentials. For instance, in March 2019, Breath Technologies announced the initiation of Phase 3 BOSTON clinical study of L-CsA-i for the treatment of bronchiolitis obliterans syndrome via a drug-specific eFlow nebulizer of PARI Pharma that is under investigation.

Request a free sample copy or view report summary: Pneumatic Nebulizers Market Report

Pneumatic Nebulizers Market Report Highlights

• The breath-actuated product segment held the dominant revenue share of the global market in 2020 owing to the increased product demand
• The hospitals & clinics end-use segment led the market in 2020 with a revenue share of more than 66% owing to the high product usage a hospitals & clinics
• In 2020, North America was the dominant regional market owing to the increased prevalence of respiratory diseases and high product adoption
• Europe accounted for the second-largest revenue share in 2020 due to increased geriatric population and awareness about the product
• Asia Pacific region is expected to register the fastest CAGR over the forecast period owing to the presence of emerging countries, such as China and India

Access Press Release@ https://www.grandviewresearch.com/press-release/global-pneumatic-nebulizer-market

Pneumatic Nebulizers Market Segmentation

Grand View Research has segmented the global pneumatic nebulizers market on the basis of the product, end-use, and region:

Pneumatic Nebulizers Product Outlook (Revenue, USD Million, 2016 - 2028)

• Breath-actuated
• Vented

Pneumatic Nebulizers End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals & Clinics
• Home Healthcare

Pneumatic Nebulizers Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa
  • Saudi Arabia

List of Key Players of Pneumatic Nebulizers Market

• Koninklijke Philips N.V.
• Omron Corp.
• PARI Pharma
• General Electric Company
• Allied Healthcare Products, Inc.
• BD (Becton, Dickinson & Company)
• GF Health Products, Inc.
• Medline Industries, Inc.
• Briggs Healthcare
• Vectura Group Plc

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare. 

Global Chile Radiotherapy Market to Reach Around USD 36.0 Million by 2028: Grand View Research Inc.

 Chile Radiotherapy Market Growth & Trends

The Chile radiotherapy market size is expected to reach USD 36.0 million by 2028, according to a new study by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.7% from 2021 to 2028. The increasing prevalence of cancer and rising healthcare expenditure are factors expected to propel the growth over the forecast period.

There is a significant gap between the required and installed radiotherapy capacity in Chile. As per a recently published report in the International Journal of Radiation Oncology, Chile had around 41 operative LINACs, which is less than the number required to meet the demand. This provides significant opportunities for growth for the market.

According to the International Agency of Research on Cancer (IARC), the estimated number of new lung cancer cases in Chile was around 4,000 in 2020. The number is expected to reach around 5,500 by 2030. The rising incidence of lung cancer can be attributed to increasing smoking. As per the national health survey, currently, 32.5% of the people in Chile are active smokers. The rising incidence of cancer is expected to drive market growth.

Moreover, companies are adopting strategies that allow them to use their resources to aid in the development of new products and enhance their supply chain. For instance, in August 2020, Siemens Healthcare GmbH announced the acquisition of Varian Medical Systems, Inc. in an all-cash transaction that accounted for USD 16.4 billion. This acquisition may enable the company to offer end-to-end oncology products to address the unmet medical needs of cancer treatment on a global scale.

Chronic adverse effects of radiotherapy occur after months or years of treatment. These effects depend on the total dose of radiotherapy received and the area of treatment. In some regions of the body, radiation treatment can lead to a buildup of body fluids and can cause lymphedema. Radiation exposure to healthy cells in the body can lead to apoptosis, senescence, necrosis, and terminal differentiation of healthy cells, which can lead to death. Radiotherapy weakens the body and can attenuate a body's receptiveness to radiation therapy or surgery. The adverse effects of radiation therapy may restrain market growth.

Request a free sample copy or view report summary: Chile Radiotherapy Market Report

Chile Radiotherapy Market Report Highlights

• In 2020, External Beam Radiation Therapy (EBRT) dominated the market and accounted for the largest revenue share of 86.5%. The high price and high installation base of EBRT equipment is one of the factors for the growth of the segment
• The internal beam radiation therapy segment is expected to witness a lucrative CAGR of 6.9% during the forecast period. The ability to deliver the precise dose, increased patient preference, and cost-effectiveness are some factors driving the segment
• The prostate cancer segment dominated the market and accounted for a share of 24.9% in the market in 2020 and is expected to continue its dominance throughout the forecast period. The high incidence and treatment rate of prostate cancer in Chile are some of the factors contributing to its dominance

Access Press Release@ https://www.grandviewresearch.com/press-release/chile-radiotherapy-market-analysis

Chile Radiotherapy Market Segmentation

Grand View Research has segmented the Chile radiotherapy market based on type and application:

Chile Radiotherapy Type Outlook (Revenue, USD Million, 2016 - 2028)

• External Beam Radiotherapy
• Internal Beam Radiotherapy
• Systemic Radiotherapy

Chile Radiotherapy Application Outlook (Revenue, USD Million, 2016 - 2028)

• Breast Cancer
• Prostate Cancer
• Lung Cancer
• Head and Neck Cancer
• Colorectal Cancer
• Others

List of Key Players of Chile Radiotherapy Market

• Varian Medical Systems, Inc.
• Elekta AB
• Accuray Incorporated
• Becton, Dickinson and Company
• Isoray Medical
• NTP Radioisotopes SOC Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Michigan Urgent Care Center Market Projected to Discern Stable Expansion by 2028

 Michigan Urgent Care Center Market Growth & Trends

The Michigan urgent care center market size is expected to reach USD 1.6 billion by 2028, based on a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 10.1% from 2021 to 2028. The market is primarily driven by the growing demand for health services, rising prevalence of diseases, and increasing disposable income of the population. A gradual shift of patients toward non-traditional settings, such as urgent care centers and walk-in clinics, owing to easy access is projected to bode well for the market growth.

An urgent care center is an obvious link between emergency room services and primary care physicians. These centers provide immediate health services to patients who need access to their primary care physicians on weekends or at night. There is no prior appointment required at approximately 900+ urgent care centers in Michigan. They can replicate nearly all the services provided in an emergency room or a traditional doctor’s office. Urgent care represents 12.6% of all outpatient physician visits and over 23% of all primary health visits in the U.S. This represents the major role urgent care centers play in the delivery of ambulatory and primary patient care. Thus, these factors are propelling the growth of the market.

To meet the increasing demand for emergency services and create awareness, urgent care centers are adopting new technologies and conducting various business activities, such as facility expansions. There is a trend of adopting new treatment options, such as telehealth, for the immediate treatment of acute illnesses and injuries. Many urgent care centers are adopting virtual consultation platforms to provide treatment during the COVID-19 pandemic. Such measures are expected to result in an increased demand for urgent care due to the growing awareness about the availability of accurate and quick treatment options because of the increased adoption of new technologies.

Request a free sample copy or view report summary: Michigan Urgent Care Center Market Report

Michigan Urgent Care Center Market Report Highlights

• The acute respiratory infection application segment dominated the market in 2020. The high number of acute respiratory infection cases, especially among children, is a primary factor fueling the segment growth. Since the symptoms of COVID-19 are similar to respiratory infections, a high number of people were visiting urgent care centers to clarify their doubts. This is propelling the growth of the segment
• The urinary tract infections application segment is anticipated to witness the fastest growth during the forecast period. An increasing number of visits due to recurring UTIs is propelling the segment growth
• Key players are involved in the inclusion of various onsite services and facilities, such as telemedicine. Therefore, the competitive rivalry in this market is likely to remain high. For instance, in January 2018, Concentra, Inc. expanded its telemedicine platform, Telemed, in New Mexico, Michigan, and Illinois. The expansion was a part of the company’s growth plan to cover the majority of states by the end of the year 2018
• Key players are also undertaking acquisitions to increase their market presence. For instance, in August 2018, Beaumont Health partnered with an Atlanta-based organization, WellStreet Urgent Care, for establishing up to 30 urgent care centers across Metro Detroit by the end of 2019

Access Press Release@ https://www.grandviewresearch.com/press-release/michigan-urgent-care-center-market-analysis

Michigan Urgent Care Center Market Segmentation

Grand View Research has segmented the Michigan urgent care center market on the basis of application:

Michigan Urgent Care Center Application Outlook (Revenue, USD Million, 2016 - 2028)

• Acute Respiratory Infection
• General Symptoms
• Tissue Issues
• Digestive System Issues
• Skin Infections
• Urinary Tract Infections
• Ear Infections
• Sprains, Strains, Fracture and Injuries
• Influenza Pneumonia
• Others

List of Key Players of Michigan Urgent Care Center Market

• American Family Care
• Concentra, Inc.
• Beaumont Health
• Nextcare Holdings, Inc.
• Lakes Urgent Care
• Livonia Urgent Care & Medical Center
• Get Well Urgent Care
• Oak Park Urgent Care
• Berkley Urgent Care
• PrimeCare Urgent Care

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.